Literature DB >> 29367088

Sinomenine inhibits fibroblast-like synoviocyte proliferation by regulating α7nAChR expression via ERK/Egr-1 pathway.

Lang Yi1, Yan-Jun Lyn1, Chong Peng1, Rui-Li Zhu1, Sha-Sha Bai1, Liang Liu2, Pei-Xun Wang1, Hua Zhou3, Yan Dong4.   

Abstract

Fibroblast like synoviocyte (FLS) is a crucial in the pathogenesis of rheumatoid arthritis (RA), and involved in inflammation and joint destruction. Sinomenine (SIN), an alkaloid derived from the plant Sinomenium acutum, has anti-inflammatory and analgesic effect and been used for RA treatment in China. Alpha 7 nicotinic acetylcholine receptors (α7nAChR), as the key receptor in cholinergic anti-inflammatory pathway (CAP) to inhibit inflammation, has been detected in RA patients synovium, but its role is still unclear. Here we investigated the association between the aggressive proliferation of FLS and α7nAChR expression and the effect of sinomenine. FLS was isolated from synovial tissues of adjuvant-induced-arthritis (AIA) rat. Tumor necrosis factor(TNF)-α was used to induce the aggressive proliferation of FLS. MTT assay was applied to evaluate the proliferation of FLS. The messenger RNA (mRNA) and protein levels of α7nAChR and early growth response gene-1 (Egr-1) were measured. The results showed that TNF-α induced FLS proliferation in vitro (P < .01) and increased the phosphorylation of ERK1/2 and the expression of Egr-1 and α7nAChR (P < .05 or P < .01). U0126, the inhibitor of ERK1/2 inhibited α7nAChR expression and FLS proliferation significantly (P < .05 or P < .01). Specific short interference RNA(siRNA) of α7nAChR decreased α7nAChR expression and inhibited FLS proliferation as well. SIN inhibited the proliferation of FLS and decreased the phosphorylation of ERK1/2, and the expression of Egr-1 and α7nAChR induced by TNF-α (P < .05). In conclusion, the expression of α7nAChR involved in the aggressive proliferation of FLS induced by TNF-α and was regulated by ERK/Egr-1 signal pathway. SIN inhibited FLS proliferation and α7nAChR expression through inhibiting ERK/Egr-1 signal pathway, this may contribute to the anti-inflammatory and anti-arthritic effect of SIN.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ERK; Fibroblast-like synoviocyte; Proliferation; Sinomenine; α7nAChR

Mesh:

Substances:

Year:  2018        PMID: 29367088     DOI: 10.1016/j.intimp.2018.01.015

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  5 in total

1.  Combined administration of SHP2 inhibitor SHP099 and the α7nAChR agonist PNU282987 protect mice against DSS‑induced colitis.

Authors:  Junhua Xiao; Gufang Zhang; Sujun Gao; Jiaqing Shen; Huang Feng; Zhilong He; Chunfang Xu
Journal:  Mol Med Rep       Date:  2020-07-10       Impact factor: 2.952

Review 2.  Natural medicines of targeted rheumatoid arthritis and its action mechanism.

Authors:  Xueling Liu; Zhiguo Wang; Hua Qian; Wenhua Tao; Ying Zhang; Chunyan Hu; Weiwei Mao; Qi Guo
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

Review 3.  Anti-Alphaviral Alkaloids: Focus on Some Isoquinolines, Indoles and Quinolizidines.

Authors:  Anne-Laure Sandenon Seteyen; Emmanuelle Girard-Valenciennes; Axelle Septembre-Malaterre; Philippe Gasque; Pascale Guiraud; Jimmy Sélambarom
Journal:  Molecules       Date:  2022-08-10       Impact factor: 4.927

4.  Injectable hyaluronic acid hydrogels encapsulating drug nanocrystals for long-term treatment of inflammatory arthritis.

Authors:  Yongsheng Gao; Douglas Vogus; Zongmin Zhao; Wei He; Vinu Krishnan; Jayoung Kim; Yujie Shi; Apoorva Sarode; Anvay Ukidve; Samir Mitragotri
Journal:  Bioeng Transl Med       Date:  2021-09-15

5.  Inhibition of Kruppel-like factor 7 attenuates cell proliferation and inflammation of fibroblast-like synoviocytes in rheumatoid arthritis through nuclear factor κB and mitogen-activated protein kinase signaling pathway.

Authors:  Jingjing Cao; Yanhui Ni; Huaxing Zhang; Xiaoran Ning; Xiaoyong Qi
Journal:  Exp Anim       Date:  2022-03-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.